OCGN - Ocugen hits a 52-week high after decision to lower quorum requirement March, 21 2024 02:40 PM Ocugen, Inc. 2024-03-21 14:40:56 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Seeking Alpha’s Quant Rating on Ocugen Historical earnings data for Ocugen Financial information for Ocugen For further details see: Ocugen hits a 52-week high after decision to lower quorum requirement